$AEHR Cashflow Statement | Understand Stock

$AEHR

$56.60 +$1.29 (2.33%) Close

$AEHR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2026 12 months to May 29, 2026	FY2025 12 months to May 30, 2025	FY2024 12 months to May 31, 2024	FY2023 12 months to May 31, 2023	FY2022 12 months to May 31, 2022
Cash flows from operating activities:
Net income (loss)
Net income (loss)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Stock-based compensation expense
Depreciation and amortization
Loss on disposal of property plant equipment
Non-cash operating lease expense
Deferred income taxes
Amortization of operating lease right-of-use assets
Impairment of assets
Accretion of investment discount
Net gain from dissolution of Aehr Test Systems Japan
Income tax benefit related to dissolution of Aehr Test Systems Japan
Provision for credit losses
Gain from forgiveness of PPP loan
Trade and other accounts receivable
Changes in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid expenses and other assets
Accounts payable
Accrued expenses
Other long-term liabilities
Deferred revenue
Operating lease liabilities
Income taxes payable
Net cash provided by (used in) operating activities

Cash flows from investing activities:
Purchases of property and equipment
Purchases of investments
Proceeds from maturities of investments
Payments for business acquisition, net of cash and cash equivalent acquired
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Proceeds from long-term debt
Line of credit (repayments) borrowings, net
Proceeds from issuance of common stock from public offerings, net of issuance costs
Line of credit repayments, net
Proceeds from issuance of common stock under employee plans
Shares repurchased for tax withholdings on vesting of restricted stock units, amount
Net cash provided by financing activities
Effect of exchange rates on cash, cash equivalents and restricted cash

Effect of exchange rate changes on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period(1)
Cash, cash equivalents and restricted cash, end of period (1)
Supplemental cash flow information:
Income taxes
Interest
Income taxes paid
Interest paid
Net transfer of equipment between inventory and property and equipment
Supplemental disclosure of non-cash flow information:
Net transfer of equipment between inventory and property and equipment
Purchases of property and equipment included in accounts payable and accrued liabilities
Common stock issuance costs included in accounts payable

Comments